We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NNN icon
76
NNN REIT
NNN
$9.36B
$444K 0.22%
+11,199
New +$459K
KMB icon
77
Kimberly-Clark
KMB
$37B
$443K 0.22%
+4,389
New +$480K
NVCR icon
78
NovoCure
NVCR
$1.97B
$443K 0.22%
+34,227
New +$439K
MAGN
79
Magnera Corp
MAGN
$490M
$442K 0.22%
+29,209
New +$338K
MANU icon
80
Manchester United
MANU
$3.96B
$442K 0.22%
+27,774
New +$448K
HAPN
81
Happen Inc
HAPN
$2.16B
$441K 0.22%
23,309
+5,704
+32% +$101K
TPC
82
Tutor Perini Cor
TPC
$4.51B
$441K 0.22%
+6,585
New +$432K
MAX icon
83
MediaAlpha
MAX
$734M
$441K 0.22%
34,034
+9,554
+39% +$117K
DOO
84
Bombardier Recreational Products
DOO
$4.53B
$440K 0.22%
6,216
-1,266
-17% -$86.2K
MP icon
85
MP Materials
MP
$7.68B
$440K 0.22%
8,706
+5,642
+184% +$358K
POOL icon
86
Pool Corp
POOL
$6.73B
$438K 0.22%
+1,914
New +$498K
POET icon
87
POET Technologies
POET
$1.22B
$437K 0.22%
+69,072
New +$438K
RBRK icon
88
Rubrik
RBRK
$15.4B
$435K 0.22%
5,682
+1,870
+49% +$143K
SPOT icon
89
Spotify
SPOT
$102B
$434K 0.22%
+747
New +$467K
DRS icon
90
Leonardo DRS
DRS
$12.9B
$433K 0.22%
+12,693
New +$468K
BRX icon
91
Brixmor Property Group
BRX
$9.93B
$430K 0.22%
+16,411
New +$433K
LAUR icon
92
Laureate Education
LAUR
$5.25B
$430K 0.22%
+12,775
New +$394K
TNDM icon
93
Tandem Diabetes Care
TNDM
$1.18B
$430K 0.22%
19,554
-2,714
-12% -$49K
PBR.A icon
94
Petrobras Class A
PBR.A
$103B
$429K 0.22%
38,047
+18,089
+91% +$209K
FIX icon
95
Comfort Systems
FIX
$60.9B
$427K 0.22%
457
+156
+52% +$144K
DVA icon
96
DaVita
DVA
$15.2B
$425K 0.22%
3,744
+2,187
+140% +$266K
HPQ icon
97
HP
HPQ
$24.3B
$424K 0.21%
+19,024
New +$485K
MNDY icon
98
monday.com
MNDY
$3.47B
$424K 0.21%
+2,871
New +$484K
INFU icon
99
InfuSystem Holdings
INFU
$189M
$421K 0.21%
+46,916
New +$449K
SYY icon
100
Sysco
SYY
$40.2B
$420K 0.21%
+5,695
New +$433K
2 3
4
5 6

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.